VSGX | VXUS | VSGX / VXUS | |
Gain YTD | 0.317 | 0.967 | 33% |
Net Assets | 3.98B | 432B | 1% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 9.00 | 4.00 | 225% |
Yield | 3.04 | 3.30 | 92% |
Fund Existence | 6 years | 14 years | - |
VSGX | VXUS | |
---|---|---|
RSI ODDS (%) | 12 days ago86% | 12 days ago86% |
Stochastic ODDS (%) | 12 days ago84% | 12 days ago82% |
Momentum ODDS (%) | 12 days ago80% | 12 days ago82% |
MACD ODDS (%) | N/A | 12 days ago88% |
TrendWeek ODDS (%) | 12 days ago80% | 12 days ago79% |
TrendMonth ODDS (%) | 12 days ago76% | 12 days ago78% |
Advances ODDS (%) | 14 days ago80% | 14 days ago78% |
Declines ODDS (%) | 12 days ago79% | 12 days ago79% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | N/A | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VTHR | 265.71 | 2.49 | +0.95% |
Vanguard Russell 3000 ETF | |||
COWG | 33.25 | 0.19 | +0.57% |
Pacer US Large Cp CA Cows Gr Ldrs ETF | |||
XBJL | 34.53 | 0.09 | +0.27% |
Innovator US Eq Acclrtd 9 Bffr ETF Jul | |||
XDJA | 28.47 | N/A | N/A |
Innovator US Equity Accelerated ETF - January | |||
CANC | 24.46 | -0.03 | -0.14% |
Tema Oncology ETF |
A.I.dvisor indicates that over the last year, VSGX has been loosely correlated with ASML. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VSGX jumps, then ASML could also see price increases.
Ticker / NAME | Correlation To VSGX | 1D Price Change % | ||
---|---|---|---|---|
VSGX | 100% | +0.46% | ||
ASML - VSGX | 62% Loosely correlated | +0.81% | ||
SAP - VSGX | 55% Loosely correlated | +0.48% | ||
ROG - VSGX | 49% Loosely correlated | +0.09% | ||
AZN - VSGX | 37% Loosely correlated | -0.46% |